Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Current Oncology (Toronto, Ont.)|October 25, 2024
Prognostic Index for Liver Radiation (PILiR)Laura Callan, Haddis Razeghi, Natalie Grindrod, et al.
Journal of Psychopharmacology (Oxford, England)|January 31, 2019
Lithium treatment for unipolar major depressive disorder: Systematic reviewJuan Undurraga, Kang Sim, Leonardo Tondo, et al.
Plos One|April 7, 2020
Moving towards culturally competent health systems for migrants? Applying systems thinking in a qualitative study in Malaysia and ThailandNicola Suyin Pocock, Zhie Chan, Tharani Loganathan, et al.
Emergency Medicine Journal : EMJ|September 22, 2021
ED syphilis and gonorrhea/chlamydia cotesting practices before and after the implementation of an electronic health record-based alertJames S Ford, Tasleem Chechi, Michella Otmar, et al.
BMC Cancer|April 27, 2019
Does external beam radiation boost to pelvic lymph nodes improve outcomes in patients with locally advanced cervical cancer?Caryn Wujanto, Bok Ai Choo, David Tan, et al.
Journal of Gynecologic Oncology|September 19, 2025
Erratum: The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women's cancer research organizationDavid Tan, Noriko Fujiwara, Keiichi Fujiwara, et al.
Journal of Gynecologic Oncology|December 22, 2024
Phase II randomized study of dostarlimab alone or with bevacizumab versus non-platinum chemotherapy in recurrent gynecological clear cell carcinoma (DOVE/APGOT-OV7/ENGOT-ov80)Jung-Yun Lee, David Tan, Isabelle Ray-Coquard, et al.
Neurointervention|February 8, 2022
The Woven EndoBridge Device for the Treatment of Intracranial Aneurysms: Initial Clinical Experience within an Australian PopulationJay Gajera, Julian Maingard, Michelle Foo, et al.
Investigational New Drugs|December 22, 2015
A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041)Joanne W Chiu, Sebastien J Hotte, Christian K Kollmannsberger, et al.
The Journal of Infectious Diseases|April 16, 2023
A Potent Recombinant Polyclonal Antibody Therapeutic for Protection Against New Severe Acute Respiratory Syndrome Coronavirus 2 Variants of ConcernNicholas P Wayham, Ariel R Niedecken, Jan Fredrik Simons, et al.
Pageof 4